Endocrinology

Host: Farhad Zangeneh, MD

Guest: Robert Busch, MD

Host Dr. Farhad Zenganah is joined by Dr. Robert Busch and they will be discussing current incretin treatment options and what is in the pipeline. They will discuss the differences between oral and injectables incretin treatment options and how clinicians can individualize treatment options for their patients, while determining the benefits and risks.

Robert Busch, MD, is a practicing endocrinologist and founding member of The Endocrine Group in Albany, New York. Dr. Busch is a member of the board of trustees at the Albany College of Pharmacy. He has enthusiastically enjoyed teaching medical students, pharmacists, physician assistants, nurse practitioners, and physicians for over 25 years.He is a principal investigator in numerous clinical trials.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA

Guest: Harold Bays, MD, FNLA

Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs.

Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville, KY. And, has served as an Investigator in over 400 Phase I - IV clinical trials for treatments for high cholesterol and other dyslipidemias, obesity, diabetes mellitus, hypertension, osteoporosis, and other metabolic and hormonal disorders. Dr. Bays has also served as Medical Director of L-MARC Research Center since 1989 - a clinical research facility originally established in 1989 - and President of L-MARC Research Center since its independent incorporation in 1998.

Host: Steven Edelman, MD

Guest: Eric Rackow, MD

The percentage of healthcare spending on chronic illnesses is increasing exponentially; critically for patients with diabetes. How can healthcare providers help their aging population to manage their diabetes and avoid costly hospital stays through home care management? Join host Dr. Steven Edelman and his guest, professor of medicine at the New York University School of Medicine, Dr. Eric Rackow, as they discuss new approaches for home care management strategies for patients living diabetes.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA

Guest: Allen Taylor, MD

Dr. Allen J. Taylor, director of advanced cardiac imaging at the Washington Hospital Center in Washington, DC, joins host Dr. Alan Brown to discuss the practical application and appropriateness of imaging guidlines related to screening for cardiovascular risk as well as carotid intima-media thickness.

Brought to you by:

Host: Alan S. Brown, MD, FACC, FAHA, FNLA

Guest: Anne Goldberg, MD

The National Lipid Association Foundation is emphasizing awareness of the most common inherited form of high cholesterol, familial hypercholesterolemia. Endocrinologist Dr. Anne Goldberg, talks with host Dr. Alan Brown about how to recognize and treat this hereditary cause of early onset atherosclerosis. Research has shown that statin treatment should begin when patients are very young. How early in life can we start screening and treating children, and are there differences to consider when treating young male versus female patients?

Brought to you by:

Host: Steven Edelman, MD

Guest: Simon Heller, MD

In 2004 the American Diabetes Association working group defined the threshold of hypoglycemia as 70 mg/dl. The clinical definition continues to attract controversy with a standard vs. dynamic solution. What are considerations that need to be made in terms of the clinical definition of hypoglycemia? Join host Dr. Steven Edelman and his guest, professor of clinical diabetes at the University of Sheffield, Dr. Simon Heller, as they discuss the challenge with the current threshold of hypoglycemia.

Host: Timothy Bailey, MD

Guest: Eric Topol, MD

The challenges of treating diabetes include long-term monitoring and management, lifestyle change and adherence to medication. How are digital technology and genomics shaping the management of diabetes? Join guest host Dr. Timothy Bailey and his guest Dr. Eric Topol, director of the Scripps Translational Science Institute, as they discuss how digital technologies can improve glucose monitoring and genomics is leading to individualized treatment. Dr. Topol, who does not have diabetes, describes his personal experience living with continuous glucose monitoring for one week.

Disclosures

Dr. Eric Topol has disclosed that he has received grants for clinical research from sanofi-avenitis. Dr. Topol has also disclosed that he has served as an advisor or consultant to sanofi-aventis and Daiichi Sankyo.

Host: Steven Edelman, MD

Guest: Linda Raynes Mahony, MS, RD, CDE

Fifty percent of patients living with diabetes will require some sort of renal replacement therapy. What percent will go on to renal transplantation and what are the recommendations for the management of these patients? Join host Dr. Steven Edelman and his guest, transplant dietitian at the University of California, San Diego, Linda Raynes Mahony, as they discuss medications, nutrition and overall management of renal transplant patients.

Host: Maurice Pickard, MD

Guest: Diana Zuckerman, PhD

The lap-band device dramatically reduces the size of a patient's stomach, and as such, it can be effective for weight loss in very obese patients. It offers at least one major advantage over gastric bypass surgery, in that the lap-band can be removed. But can the lap-band procedure also be safe and effective for patients who are even slightly obese, or do the potential risks outweigh the benefits for these patients? Dr. Diana Zuckerman, president of the National Research Center for Women & Families and its cancer prevention and treatment fund in Washington, D.C., discusses the criteria for patients to receive lap-banding. What concerns surround the issue of lowering the body-mass index (or BMI) threshold for patients eligible for this procedure? What are the long-term risks of lap-bands? Dr. Maurice Pickard hosts.

Host: Steven Edelman, MD

Guest: Edward Damiano, PhD

Guest: Steven Russell, MD, PhD

The latest research into the use of glucagon and insulin in a closed-loop system is promising for the management of type 1 diabetes. How will the use of a bihormonal system benefit patients, and what is the path of treatment? Join host Dr. Steven Edelman and his guests, associate professor of biomedical engineering at Boston University, Dr. Edward Damiano, and instructor of medicine at Harvard Medical School, Dr. Steven Russell, as they discuss the challenges of a closed-loop system.